Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study
IntroductionAlthough pegylated interferon (PEG-IFN) has been widely used in the treatment of polycythemia vera (PV), there is still a significant variability in its specific dosage and administration.MethodsThis single-center retrospective study assessed the efficacy and safety of PEG-IFN in JAK2V61...
Saved in:
Main Authors: | Long Chang, Wen-Xin Li, Hao Cai, Jian Li, Ming-Hui Duan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1586839/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
POLYCYTHEMIA VERA IDENTIFIED IN A PATIENT WITH RESTENOSIS OF THE SUPERFICIAL FEMORAL ARTERY. CLINICAL CASE AND REVIEW OF THE LITERATURE
by: G. Sh. Safuanova, et al.
Published: (2017-05-01) -
All we know about polycythemia vera: literature review and own experience
by: K. M. Abdulkadyrov, et al.
Published: (2015-10-01) -
A Real World Study: Efficacy and Safety of Pegylated Interferon Alpha-2a in Patients with Myeloproliferative Neoplasm
by: Derya Koyun, et al.
Published: (2025-03-01) -
From Diagnosis to Health Practice: Polycythemia Vera. A Literature Review
by: Katarzyna Siekaniec, et al.
Published: (2025-07-01) -
How we treat polycythemia vera
by: V. A. Shuvaev, et al.
Published: (2024-01-01)